On October 11-12, 2012, the chief physician of Helss Clinic Irina Nosova and the endocrinologist of the clinic Natalia Psyuk took part in a research meeting in Berlin, Germany.
The meeting was devoted to the treatment of patients suffering from type 2 diabetes with concomitant diseases of the cardiovascular system.
Information was presented on a sugar reducing drug for regular intake of a new generation that stimulates insulin production only in the case of an elevated blood glucose level, and also reduces the risk of the onset and progression of the concomitant pathology of the cardiovascular system.
